Your browser doesn't support javascript.
loading
In vitro lytic activity and antifungal susceptibility of infrequently isolated yeasts.
Montoya, Alexandra M; Luna-Rodríguez, Carolina E; Gracia-Robles, Gabriela; Rojas, Olga C; González, Gloria M.
Afiliação
  • Montoya AM; Departamento de Microbiología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Ave. Francisco I. Madero s/n, 64460, Monterrey, Mexico.
  • Luna-Rodríguez CE; Departamento de Microbiología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Ave. Francisco I. Madero s/n, 64460, Monterrey, Mexico.
  • Gracia-Robles G; Departamento de Microbiología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Ave. Francisco I. Madero s/n, 64460, Monterrey, Mexico.
  • Rojas OC; Vicerectoría de Ciencias de la Salud, Departamento de Ciencias Básicas, Universidad de Monterrey, Ave. Morones Prieto 4500 Pte, 66238, San Pedro Garza García, Mexico.
  • González GM; Departamento de Microbiología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Ave. Francisco I. Madero s/n, 64460, Monterrey, Mexico. gmglez@yahoo.com.mx.
Arch Microbiol ; 201(8): 1147-1149, 2019 Oct.
Article em En | MEDLINE | ID: mdl-31147748
Non-albicans Candida species have acquired relevance in the last decades as a cause of serious disease. The virulence factors and antifungal susceptibility of these rare pathogens remain largely unrecognized. We examined a total of 50 yeast isolates corresponding to 11 different infrequently isolated yeast species for their in vitro enzymatic profile and susceptibility pattern as first-line antifungals. We found aspartyl protease activity for 100% of the isolates tested as well as variable DNAse, hemolysin, phospholipase and esterase activities. All strains had low MICs for amphotericin B and showed a variable response to fluconazole (0.125-32 µg/mL) and the echinocandins tested (0.25-> 8 µg/mL).
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Candida / Fluconazol / Anfotericina B / Equinocandinas / Antifúngicos Limite: Humans Idioma: En Revista: Arch Microbiol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: México País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Candida / Fluconazol / Anfotericina B / Equinocandinas / Antifúngicos Limite: Humans Idioma: En Revista: Arch Microbiol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: México País de publicação: Alemanha